CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 56.79
-0.41 (-0.72%)
Sep 8, 2025, 3:04 PM CST
SHE:300765 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -86.05 | 53.73 | 434.44 | 726.28 | 393.23 | 299.84 | Upgrade |
Depreciation & Amortization | 220.92 | 217.25 | 155.56 | 72.94 | 69.15 | 53.42 | Upgrade |
Other Amortization | 0.12 | 0.07 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -2.33 | -0.55 | - | 4.61 | - | 0.43 | Upgrade |
Asset Writedown & Restructuring Costs | 4.16 | 2.94 | 1.82 | - | 13.19 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.33 | 0.89 | -12.58 | -16.82 | -21.31 | -27.37 | Upgrade |
Provision & Write-off of Bad Debts | 3.97 | -2.95 | -4.85 | 7.8 | 6.03 | -1.41 | Upgrade |
Other Operating Activities | -449.96 | -361.62 | -305.12 | -54.64 | 9.16 | 2 | Upgrade |
Change in Accounts Receivable | 321.79 | 253.91 | 224.79 | -224.89 | -119.21 | 38.91 | Upgrade |
Change in Inventory | -135.41 | -176.63 | -9.17 | -24.82 | -113.85 | 13.23 | Upgrade |
Change in Accounts Payable | -322.28 | -1,219 | 1,081 | 157.24 | 56.71 | -32.27 | Upgrade |
Change in Other Net Operating Assets | - | - | -845.85 | - | - | - | Upgrade |
Operating Cash Flow | -445.42 | -1,235 | 721.14 | 640.72 | 292.09 | 349.07 | Upgrade |
Operating Cash Flow Growth | - | - | 12.55% | 119.36% | -16.32% | 10.68% | Upgrade |
Capital Expenditures | -385.5 | -477.78 | -581.42 | -114.05 | -195.41 | -117.74 | Upgrade |
Sale of Property, Plant & Equipment | 0.41 | 3.81 | 11.24 | 5.82 | 2.3 | 2.84 | Upgrade |
Divestitures | - | - | - | - | 118.79 | - | Upgrade |
Investment in Securities | -344 | -820 | -1 | 416.52 | -88.46 | 435.95 | Upgrade |
Other Investing Activities | 5.72 | 2.53 | - | 3.59 | 7.43 | 25.12 | Upgrade |
Investing Cash Flow | -723.37 | -1,291 | -571.18 | 311.88 | -155.36 | 346.17 | Upgrade |
Long-Term Debt Issued | - | - | - | 20 | - | - | Upgrade |
Total Debt Issued | - | - | - | 20 | - | - | Upgrade |
Long-Term Debt Repaid | - | -1.57 | -20.86 | -0.86 | -0.86 | - | Upgrade |
Total Debt Repaid | -1.8 | -1.57 | -20.86 | -0.86 | -0.86 | - | Upgrade |
Net Debt Issued (Repaid) | -1.8 | -1.57 | -20.86 | 19.14 | -0.86 | - | Upgrade |
Issuance of Common Stock | - | - | 1,989 | - | - | - | Upgrade |
Repurchase of Common Stock | -94.04 | -316.78 | -4.25 | -0.07 | - | - | Upgrade |
Common Dividends Paid | -27.85 | -374.16 | -97.85 | -82.07 | -42 | -28 | Upgrade |
Other Financing Activities | 605 | 300 | -480.01 | - | - | - | Upgrade |
Financing Cash Flow | 481.31 | -392.51 | 1,386 | -63.01 | -42.86 | -28 | Upgrade |
Foreign Exchange Rate Adjustments | 26.64 | 7.8 | 30.82 | 57.55 | -6.88 | -2.13 | Upgrade |
Net Cash Flow | -660.84 | -2,911 | 1,567 | 947.14 | 86.98 | 665.11 | Upgrade |
Free Cash Flow | -830.92 | -1,713 | 139.72 | 526.67 | 96.67 | 231.33 | Upgrade |
Free Cash Flow Growth | - | - | -73.47% | 444.79% | -58.21% | 10.53% | Upgrade |
Free Cash Flow Margin | -40.37% | -86.47% | 5.50% | 20.05% | 5.23% | 17.56% | Upgrade |
Free Cash Flow Per Share | -0.60 | -1.22 | 0.10 | 0.39 | 0.07 | 0.20 | Upgrade |
Cash Income Tax Paid | 82.64 | 118.12 | 5.46 | 93.04 | 108.71 | 132.48 | Upgrade |
Levered Free Cash Flow | 100.12 | -1,164 | 1,127 | 434.79 | -59.54 | 33.68 | Upgrade |
Unlevered Free Cash Flow | 107.19 | -1,160 | 1,138 | 434.92 | -57.76 | 33.68 | Upgrade |
Change in Working Capital | -135.91 | -1,145 | 451.86 | -99.45 | -177.36 | 22.16 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.